Iris Pigmented Lesions and Risk of Cutaneous Melanoma: Case–Control Study in Lithuania
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Clinical Examination
2.3. Data Analysis
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Naik, P.P. Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management. World J. Oncol. 2021, 12, 7–19. [Google Scholar] [CrossRef] [PubMed]
- Garbe, C.; Keim, U.; Gandini, S.; Amaral, T.; Katalinic, A.; Hollezcek, B.; Martus, P.; Flatz, L.; Leiter, U.; Whiteman, D. Epidemiology of Cutaneous Melanoma and Keratinocyte Cancer in White Populations 1943–2036. Eur. J. Cancer 2021, 152, 18–25. [Google Scholar] [CrossRef] [PubMed]
- Tripp, M.K.; Watson, M.; Balk, S.J.; Swetter, S.M.; Gershenwald, J.E. State of the Science on Prevention and Screening to Reduce Melanoma Incidence and Mortality: The Time Is Now. CA Cancer J. Clin. 2016, 66, 460–480. [Google Scholar] [CrossRef] [PubMed]
- Arnold, M.; Singh, D.; Laversanne, M.; Vignat, J.; Vaccarella, S.; Meheus, F.; Cust, A.E.; De Vries, E.; Whiteman, D.C.; Bray, F. Global Burden of Cutaneous Melanoma in 2020 and Projections To 2040. JAMA Dermatol. 2022, 158, 495. [Google Scholar] [CrossRef]
- Dulskas, A.; Cerkauskaite, D.; Vincerževskiene, I.; Urbonas, V. Trends in Incidence and Mortality of Skin Melanoma in Lithuania 1991–2015. Int. J. Environ. Res. Public Health 2021, 18, 4165. [Google Scholar] [CrossRef] [PubMed]
- Belbasis, L.; Stefanaki, I.; Stratigos, A.J.; Evangelou, E. Non-Genetic Risk Factors for Cutaneous Melanoma and Keratinocyte Skin Cancers: An Umbrella Review of Meta-Analyses. J. Dermatol. Sci. 2016, 84, 330–339. [Google Scholar] [CrossRef]
- Naldi, L.; Altieri, A.; Imberti, G.L.; Gallus, S.; Bosetti, C.; La Vecchia, C. Sun Exposure, Phenotypic Characteristics, and Cutaneous Malignant Melanoma. An Analysis According to Different Clinico-Pathological Variants and Anatomic Locations (Italy). Cancer Causes Control 2005, 16, 893–899. [Google Scholar] [CrossRef] [PubMed]
- Conforti, C.; Zalaudek, I. Epidemiology and Risk Factors of Melanoma: A Review. Dermatol. Pract. Concept. 2021, 11, e2021161S. [Google Scholar] [CrossRef] [PubMed]
- Toth-Molnar, E.; Olah, J.; Dobozy, A.; Hammer, H. Ocular Pigmented Findings in Patients with Dysplastic Naevus Syndrome. Melanoma Res. 2004, 14, 43–47. [Google Scholar] [CrossRef] [PubMed]
- Csoma, R.Z.; Tóth-Molnár, E.; Varga, A.; Szabó, H.; Orvos, H.; Kemény, L.; Oláh, J. Risk Factors and Relationship of Cutaneous and Uveal Melanocytic Lesions in Monozygotic and Dizygotic Twin Pairs. PLoS ONE 2016, 11, e0160146. [Google Scholar] [CrossRef]
- Zanetti, R.; Rosso, S.; Martinez, C.; Nieto, A.; Miranda, A.; Mercier, M.; Loria, D.I.; Østerlind, A.; Greinert, R.; Navarro, C.; et al. Comparison of Risk Patterns in Carcinoma and Melanoma of the Skin in Men: A Multi-Centre Case-Case-Control Study. Br. J. Cancer 2006, 94, 743–751. [Google Scholar] [CrossRef] [PubMed]
- Ballester, I.; Oliver, V.; Bañuls, J.; Moragón, M.; Valcuende, F.; Botella-Estrada, R.; Nagore, E. Estudio Multicéntrico de Casos y Controles Sobre Factores de riesgo de Desarrollar Un Melanoma Cutáneo En La Comunidad. Actas Dermo-Sifiliogr. 2012, 103, 790–797. [Google Scholar] [CrossRef] [PubMed]
- Schwab, C.; Mayer, C.; Zalaudek, I.; Riedl, R.; Richtig, M.; Wackernagel, W.; Hofmann-Wellenhof, R.; Richtig, G.; Langmann, G.; Tarmann, L.; et al. Iris Freckles a Potential Biomarker for Chronic Sun Damage. Investig. Ophthalmol. Vis. Sci. 2017, 58, BIO174–BIO179. [Google Scholar] [CrossRef]
- Grigore, M.; Furtunescu, F.; Minca, D.; Costache, M.; Garbe, C.; Simionescu, O. The Iris Signal: Blue Periphery, Tan Collaret and Freckles Pattern—Strong Indicators for Epidermal Skin Cancer in South-Eastern Europe. J. Eur. Acad. Dermatol. Venereol. 2018, 32, 1662–1667. [Google Scholar] [CrossRef] [PubMed]
- Laino, A.M.; Berry, E.G.; Jagirdar, K.; Lee, K.J.; Duffy, D.L.; Soyer, H.P.; Sturm, R.A. Iris Pigmented Lesions as a Marker of Cutaneous Melanoma Risk: An Australian Case–Control Study. Br. J. Dermatol. 2018, 178, 1119–1127. [Google Scholar] [CrossRef] [PubMed]
- Simionescu, O.; Grigore, M.; Furtunescu, F.; Minca, D.; Chitu, V.; Costache, M. A Novel Iris Colour Classification Scale. Annu. Res. Rev. Biol. 2014, 4, 2525–2534. [Google Scholar] [CrossRef]
- Valiukeviciene, S.; Miseviciene, I.; Gollnick, H. The Prevalence of Common Acquired Melanocytic Nevi and the Relationship with Skin Type Characteristics and Sun Exposure among Children in Lithuania. Arch. Dermatol. 2005, 141, 579–586. [Google Scholar] [CrossRef] [PubMed]
- Institute of Hygiene. Lithuanian Health Statistics. Available online: https://stat.hi.lt (accessed on 6 November 2023).
- Katsara, M.A.; Nothnagel, M. True Colors: A Literature Review on the Spatial Distribution of Eye and Hair Pigmentation. Forensic Sci. Int. Genet. 2019, 39, 109–118. [Google Scholar] [CrossRef] [PubMed]
- Schmidt-Pokrzywniak, A.; Jöckel, K.H.; Bornfeld, N.; Sauerwein, W.; Stang, A. Positive Interaction Between Light Iris Color and Ultraviolet Radiation in Relation to the Risk of Uveal Melanoma. A Case-Control Study. Ophthalmology 2009, 116, 340–348. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Control Group n = 182 | Case Group n = 180 | p-Value |
---|---|---|---|
Sex, % (n 1) | 0.892 | ||
Male | 37.9 (69) | 37.2 (67) | |
Female | 62.1 (113) | 62.8 (113) | |
Total | 182 | 180 | |
Age (years), mean (SD 2) | |||
Male | 57.97 (8.20) | 60.70 (13.50) | 0.155 |
Female | 57.34 (7.83) | 58.88 (11.89) | 0.249 |
Total | 57.58 (7.95) | 59.56 (12.51) | 0.072 |
Age groups (years), % (n) | |||
≤50 | 23.6 (43) | 22.8 (41) | |
51–60 | 25.8 (47) | 26.7 (48) | 0.974 |
≥61 | 50.5 (92) | 50.6 (91) | |
Skin color, % (n) | |||
Fair | 29.6 (52) | 48.6 (87) | |
Medium | 65.9 (116) | 40.8 (73) | <0.001 |
Olive | 4.6 (8) | 10.61 (19) | |
Skin type (Fitzpatrick scale), % (n) | |||
Type I | 15.3 (27) | 21.7 (39) | |
Type II | 39.5 (70) | 36.1 (65) | 0.061 |
Type III | 30.5 (54) | 21.1 (38) | |
Type IV | 14.7 (26) | 21.1 (38) | |
Hair color, % (n) | |||
Light brown | 51.7 (91) | 62.0 (111) | |
Dark brown | 33.5 (59) | 25.1 (45) | 0.134 |
Black | 14.8 (26) | 12.8 (23) | |
Iris periphery color, % (n) | |||
Blue/grey | 70.5 (124) | 70.1 (122) | |
Green | 14.2 (25) | 13.2 (23) | |
Hazel | 6.3 (11) | 8.6 (15) | 0.730 |
Light brown | 6.3 (11) | 6.9 (12) | |
Dark brown | 2.8 (5) | 1.2 (2) | |
Iris collaret color, % (n) | |||
Blue | 63.1 (111) | 62.6 (109) | |
Light brown | 31.8 (56) | 28.7 (50) | 0.397 |
Dark brown | 5.1 (9) | 8.6 (15) | |
Presence of pigmented iris lesions, % (n) | <0.001 | ||
Yes | 48.9 (86) | 94.8 (165) | |
No | 51.1 (90) | 5.2 (9) | |
Average number of pigmented iris lesions, median (range) | 0.5 (0–19.5) | 2.5 (0–30) | <0.001 |
Familiar anamnesis of cutaneous melanoma, % (n) | 0.541 | ||
Yes | 2.2 (4) | 3.3 (6) | |
No | 97.8 (178) | 96.7 (174) | |
Number of melanocytic nevi, mean (SD) | |||
Diameter 2–5 mm | 8.31 (14.39) | 28.81 (28.20) | <0.001 |
Diameter ≥ 5 mm | 1.58 (3.4) | 4.79 (6.33) | <0.001 |
Number of melanocytic nevi, median (range) | |||
Diameter 2–5 mm | 4 (0–131) | 19.5 (0–194) | <0.001 |
Diameter ≥ 5 mm | 0 (0–25) | 3 (0–51) | <0.001 |
Iris Patterns | Control Group | Case Group | p-Value |
---|---|---|---|
111 1, % (n 2) | 30.7 (54) | 53.9 (97) | <0.001 |
110 3, % (n) | 27.8 (49) | 2.3 (4) | <0.001 |
121 4, % (n) | 5.1 (9) | 9.4 (17) | 0.097 |
321 5, % (n) | 3.4 (6) | 7.2 (13) | 0.094 |
221 6, % (n) | 3.4 (6) | 6.7 (12) | 0.154 |
Odds Ratio | 95% Confidence Interval | p-Value | ||
---|---|---|---|---|
Lower Bound | Upper Bound | |||
Sex, female (reference) | 0.97 | 0.64 | 1.49 | 0.892 |
Age | 1.02 | 0.99 | 1.04 | 0.073 |
Age groups, ≤50 (reference) | ||||
51–60 | 1.07 | 0.60 | 1.93 | 0.819 |
≥61 | 1.04 | 0.62 | 1.74 | 0.889 |
Skin color, olive (reference) * | ||||
Fair | 0.66 | 0.27 | 1.64 | 0.370 |
Medium | 0.26 | 0.11 | 0.62 | 0.003 |
Skin type (Fitzpatrick scale), type IV (reference) * | ||||
Type I | 1.11 | 0.54 | 2.31 | 0.778 |
Type II | 0.50 | 0.26 | 0.95 | 0.036 |
Type III | 0.67 | 0.37 | 1.23 | 0.197 |
Hair color, black (reference) * | ||||
Light brown | 1.41 | 0.75 | 2.67 | 0.287 |
Dark brown | 0.90 | 0.45 | 1.80 | 0.772 |
Iris periphery color, dark brown (reference) * | ||||
Blue/grey | 2.59 | 0.49 | 13.68 | 0.263 |
Green | 2.76 | 0.48 | 15.81 | 0.255 |
Hazel | 3.73 | 0.60 | 23.10 | 0.157 |
Light brown | 3.02 | 0.48 | 19.04 | 0.239 |
Iris collaret color, dark brown (reference) * | ||||
Blue | 0.61 | 0.25 | 1.48 | 0.278 |
Light brown | 0.59 | 0.24 | 1.50 | 0.269 |
Presence of pigmented iris lesions * | 18.75 | 8.99 | 39.12 | <0.001 |
Average number of pigmented iris lesions * | 1.13 | 1.06 | 1.21 | <0.001 |
Positive familiar anamnesis of cutaneous melanoma * | 1.53 | 0.42 | 5.55 | 0.515 |
Number of melanocytic nevi, median (range) * | ||||
Diameter 2–5 mm | 1.07 | 1.05 | 1.10 | <0.001 |
Diameter ≥ 5 mm | 1.22 | 1.13 | 1.32 | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Šemeklis, L.; Kapitanovaitė, L.; Butrimas, G.; Briedė, K.; Dubinskaitė, A.; Žemaitienė, R.; Valiukevičienė, S. Iris Pigmented Lesions and Risk of Cutaneous Melanoma: Case–Control Study in Lithuania. J. Pers. Med. 2024, 14, 530. https://doi.org/10.3390/jpm14050530
Šemeklis L, Kapitanovaitė L, Butrimas G, Briedė K, Dubinskaitė A, Žemaitienė R, Valiukevičienė S. Iris Pigmented Lesions and Risk of Cutaneous Melanoma: Case–Control Study in Lithuania. Journal of Personalized Medicine. 2024; 14(5):530. https://doi.org/10.3390/jpm14050530
Chicago/Turabian StyleŠemeklis, Lukas, Laura Kapitanovaitė, Grinvydas Butrimas, Kamilija Briedė, Augustė Dubinskaitė, Reda Žemaitienė, and Skaidra Valiukevičienė. 2024. "Iris Pigmented Lesions and Risk of Cutaneous Melanoma: Case–Control Study in Lithuania" Journal of Personalized Medicine 14, no. 5: 530. https://doi.org/10.3390/jpm14050530
APA StyleŠemeklis, L., Kapitanovaitė, L., Butrimas, G., Briedė, K., Dubinskaitė, A., Žemaitienė, R., & Valiukevičienė, S. (2024). Iris Pigmented Lesions and Risk of Cutaneous Melanoma: Case–Control Study in Lithuania. Journal of Personalized Medicine, 14(5), 530. https://doi.org/10.3390/jpm14050530